Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1002017.RAiPgOMcAUBEnhwXzeuY9kKnJhRjgKteFm24HrTldoAEg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1002017.RAiPgOMcAUBEnhwXzeuY9kKnJhRjgKteFm24HrTldoAEg130_assertion type Assertion NP1002017.RAiPgOMcAUBEnhwXzeuY9kKnJhRjgKteFm24HrTldoAEg130_head.
- NP1002017.RAiPgOMcAUBEnhwXzeuY9kKnJhRjgKteFm24HrTldoAEg130_assertion description "[Short term studies with dornase alfa in patients with more severe pulmonary disease (FVC < 40% of predicted value) and in those with acute infectious exacerbations did not reveal any significant improvements in pulmonary function, although long term studies are required to fully determine efficacy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1002017.RAiPgOMcAUBEnhwXzeuY9kKnJhRjgKteFm24HrTldoAEg130_provenance.
- NP1002017.RAiPgOMcAUBEnhwXzeuY9kKnJhRjgKteFm24HrTldoAEg130_assertion evidence source_evidence_literature NP1002017.RAiPgOMcAUBEnhwXzeuY9kKnJhRjgKteFm24HrTldoAEg130_provenance.
- NP1002017.RAiPgOMcAUBEnhwXzeuY9kKnJhRjgKteFm24HrTldoAEg130_assertion SIO_000772 7533697 NP1002017.RAiPgOMcAUBEnhwXzeuY9kKnJhRjgKteFm24HrTldoAEg130_provenance.
- NP1002017.RAiPgOMcAUBEnhwXzeuY9kKnJhRjgKteFm24HrTldoAEg130_assertion wasDerivedFrom befree-20150227 NP1002017.RAiPgOMcAUBEnhwXzeuY9kKnJhRjgKteFm24HrTldoAEg130_provenance.
- NP1002017.RAiPgOMcAUBEnhwXzeuY9kKnJhRjgKteFm24HrTldoAEg130_assertion wasGeneratedBy ECO_0000203 NP1002017.RAiPgOMcAUBEnhwXzeuY9kKnJhRjgKteFm24HrTldoAEg130_provenance.